About Kellie Rademacher, PharmD, Vice President, Access Experience Team, Precision for Value

This author has not yet filled in any details.
So far Kellie Rademacher, PharmD, Vice President, Access Experience Team, Precision for Value has created 2 blog entries.

CMS Guidance Accepts Use of Copay Accumulator Programs in Healthcare Exchanges

The CMS has announced that individual markets, small and large group, and self-insured group health plans will be allowed to implement copay accumulator programs starting in 2020. What does this mean for market access? Kellie Rademacher provides an overview.

Understanding Payer Perspectives on Orphan Drugs

Kellie Rademacher and Hetty Lima from the Payer Access Solutions team provide guidance into evaluation and valuation in the orphan drug space, currently one of the most active areas of drug development. With the FDA working to streamline the approval process for innovative orphan drugs, there is much promise on the horizon for providing breakthrough treatments, but also unique challenges with payers with regard to pricing and value.

By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.

OK